CA2368719A1 - Cinquante proteines humaines secretees - Google Patents
Cinquante proteines humaines secretees Download PDFInfo
- Publication number
- CA2368719A1 CA2368719A1 CA002368719A CA2368719A CA2368719A1 CA 2368719 A1 CA2368719 A1 CA 2368719A1 CA 002368719 A CA002368719 A CA 002368719A CA 2368719 A CA2368719 A CA 2368719A CA 2368719 A1 CA2368719 A1 CA 2368719A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polypeptide
- sequence
- present
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Cette invention a trait à de nouvelles protéines humaines sécrétées ainsi qu'à des acides nucléiques contenant les régions codantes des gènes codant ces protéines. Elle porte également sur des vecteurs, des cellules hôtes et des anticorps ainsi que sur des techniques de recombinaison permettant de mettre au point des protéines humaines sécrétées. Elle concerne, en outre, des méthodes diagnostiques et thérapeutiques, des plus utiles en matière de diagnostic et de traitement de troubles liés à ces nouvelles protéines humaines.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12650799P | 1999-03-26 | 1999-03-26 | |
US60/126,507 | 1999-03-26 | ||
US17487200P | 2000-01-07 | 2000-01-07 | |
US60/174,872 | 2000-01-07 | ||
PCT/US2000/007578 WO2000058494A1 (fr) | 1999-03-26 | 2000-03-23 | Cinquante proteines humaines secretees |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2368719A1 true CA2368719A1 (fr) | 2000-10-05 |
Family
ID=26824741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002368719A Abandoned CA2368719A1 (fr) | 1999-03-26 | 2000-03-23 | Cinquante proteines humaines secretees |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171626A4 (fr) |
JP (1) | JP2002539841A (fr) |
AU (1) | AU3908600A (fr) |
CA (1) | CA2368719A1 (fr) |
WO (1) | WO2000058494A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111467385A (zh) * | 2019-01-24 | 2020-07-31 | 深圳市华大农业应用研究院 | 组合物在预防或治疗神经退行性疾病中的用途 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020048777A1 (en) | 1999-12-06 | 2002-04-25 | Shujath Ali | Method of diagnosing monitoring, staging, imaging and treating prostate cancer |
FR2819824A1 (fr) * | 2001-01-23 | 2002-07-26 | Molecular Engines Laboratoires | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
IL164376A0 (en) * | 2002-04-03 | 2005-12-18 | Applied Research Systems | Ox4or binding agents, their preparation and pharmaceutical compositions containing them |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4235755A1 (de) * | 1992-10-23 | 1994-04-28 | Kaercher Gmbh & Co Alfred | Hochdruckreinigungsgerät |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
US5654170A (en) * | 1994-10-12 | 1997-08-05 | Johns Hopkins University | Polycystic kidney disease gene |
US5750370A (en) * | 1995-06-06 | 1998-05-12 | Human Genome Sciences, Inc. | Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor |
US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
WO1998039448A2 (fr) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 nouvelles proteines secretees |
EP0973892A2 (fr) * | 1997-03-14 | 2000-01-26 | Human Genome Sciences, Inc. | 28 proteines secretees par l'homme |
AU6952998A (en) * | 1997-04-08 | 1998-10-30 | Human Genome Sciences, Inc. | 20 human secreted proteins |
-
2000
- 2000-03-23 CA CA002368719A patent/CA2368719A1/fr not_active Abandoned
- 2000-03-23 EP EP00918240A patent/EP1171626A4/fr not_active Withdrawn
- 2000-03-23 AU AU39086/00A patent/AU3908600A/en not_active Abandoned
- 2000-03-23 WO PCT/US2000/007578 patent/WO2000058494A1/fr not_active Application Discontinuation
- 2000-03-23 JP JP2000608773A patent/JP2002539841A/ja not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111467385A (zh) * | 2019-01-24 | 2020-07-31 | 深圳市华大农业应用研究院 | 组合物在预防或治疗神经退行性疾病中的用途 |
CN111467385B (zh) * | 2019-01-24 | 2022-05-17 | 深圳市华大农业应用研究院 | 组合物在预防或治疗神经退行性疾病中的用途 |
Also Published As
Publication number | Publication date |
---|---|
AU3908600A (en) | 2000-10-16 |
JP2002539841A (ja) | 2002-11-26 |
EP1171626A4 (fr) | 2002-10-30 |
WO2000058494A1 (fr) | 2000-10-05 |
EP1171626A1 (fr) | 2002-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2368068A1 (fr) | 27 proteines humaines secretees | |
CA2368927A1 (fr) | Quarante-cinq proteines humaines secretees | |
CA2387696A1 (fr) | 48 proteines humaines secretees | |
CA2364630A1 (fr) | 50 proteines humaines secretees | |
CA2365223A1 (fr) | Proteines humaines secretees (46) | |
CA2368281A1 (fr) | 50 proteines humaines secretees | |
WO2000061620A1 (fr) | 49 proteines humaines secretees | |
CA2368467A1 (fr) | 50 proteines humaines secretees | |
CA2391364A1 (fr) | 47 proteines humaines secretees | |
CA2368302A1 (fr) | 49 proteines secretees par un etre humain | |
WO2000043495A2 (fr) | Proteines humaines secretees (33) | |
CA2365522A1 (fr) | 48 proteines secretees humaines | |
CA2391361A1 (fr) | 47 proteines secretees humaines | |
CA2370441A1 (fr) | 50 proteines humaines secretees | |
CA2368719A1 (fr) | Cinquante proteines humaines secretees | |
CA2390946A1 (fr) | 49 proteines secretees humaines | |
CA2368442A1 (fr) | 48 proteines humaines secretees | |
CA2368374A1 (fr) | 47 proteines humaines secretees | |
CA2365247A1 (fr) | Proteines humaines secretees (49) | |
CA2382769A1 (fr) | 42 proteines humaines secretees | |
CA2368700A1 (fr) | Quarante-neuf proteines humaines secretees | |
CA2368916A1 (fr) | 49 proteines humaines secretees | |
CA2365238A1 (fr) | 48 proteines humaines secretees | |
CA2368482A1 (fr) | 50 proteines humaines secretees | |
CA2369458A1 (fr) | 47 proteines humaines secretees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |